AI-generated summary
In this rat study, the authors tested a heterologous fibrin biopolymer, alone or with photobiomodulation at 660 nm, after partial injury to the calcaneus tendon. The authors report that both treatments reduced edema and that the fibrin biopolymer alone gave the greatest edema reduction and better tendon repair. They note that clinical trials are still needed.
- Participants
- 84
- Who or what was studied
- Rattus norvegicus rats with partial transection of the calcaneus tendon
- Wavelengths
- 660 nm
- Limits stated in the abstract
- This is an animal study, and the authors state that future clinical trials will be needed to validate the approach.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 40 mW
- Total energy
- 0.23 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Collagen, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.